Rare disease news, mapped to the diseases behind the headlines. AI-classified across pipeline, policy, funding, science, and community.
Be among the first to receive Kisho Intelligence Briefings
Showing news related to
Showing 1–1 of 1 stories
Mayo Clinic's research demonstrates the effectiveness of CRISPR-based gene editing in targeting the PKD1 gene mutation responsible for polycystic kidney disease. This breakthrough offers a potential shift in treatment, moving beyond merely slowing disease progression to directly correcting the genetic cause.
Get the week's most important rare disease developments — pipeline moves, policy changes, and funding signals — delivered to your inbox every Monday.
Free weekly briefing. Unsubscribe anytime.